Block D Lecture 1 - Asthma and COPD Flashcards

1
Q

What is asthma?

A

A chronic respiratory disease which is characterised by the hyper-responsiveness of the airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are 3 symptoms of asthma?

A

Answers Include:

Wheezing

Coughing

Shortness of breath

Chest tightness / pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are 4 types of non-specific stimuli?

A

Exercise

Cold Air

Hyperventilation

Chemical Agents

(Slide 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are 2 types of specific stimuli and what are they specific to?

A

Allergens - specific to asthmatics that respond to allergens

Aspirin - specific to patients which display hyper-responsiveness to aspirin

(Slide 3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 4 characteristics of asthma?

A

Answers Include:

Inflammatory Response (e.g Eosinophils, mast cells and neutrophils)

Hyper-responsiveness of smooth muscle to substances which cause contraction to smooth muscle (e.g acetylcholine)

Hypo-responsiveness of the smooth muscle to substances which relax smooth muscle (such as adrenaline)

Neuronal imbalance - overactive parasympathetic nervous system

Hyperplasia (an increase in the number of cells in a tissue or organ, leading to enlargement)

Hypertrophy ( an increase in the size of cells or tissues, often resulting in an increase in the overall size of an organ or part of the body, such as muscle tissue through exercise)

(Slide 4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the early phase of asthma?

A

Where inflammatory cells are recruited into the interstitial fluid and smooth muscle.

Mast cells release constrictor mediators which activate vagal afferent nerves, causing reflex bronchoconstriction.

(Slide 7)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is late phase asthma?

A

Eosinophils take up residence in the lung and release agents such as oxygen radicals, major basic protein and PAF.

This results in a potent killing and damaging effect upon epithelial cells and extensive damage to the epithelial lining is achieved

(Slide 7)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How are mast cells, eosinophils and neutrophils involved in asthma?

A

Mast cells: respond to the allergen and IgE by releasing histamine, TNF-α, LTC4 and LTD4 and various interleukins such as IL-1 - cause bronchoconstriction in the early phase of asthma

Eosinophils: release PAF, TNF-α, oxygen, eotaxin, MBP, eosinophil peroxidase, IL-4, IL-5, IL-1β, IL-6, which cause epithelial damage or activate other cells (such as leucocytes or smooth muscle cells)

Neutrophils: release ROS species, neutrophil elastase, myeloperoxidase (damages epithelial cells)

(Slide 8)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Are most cases of asthma TH1 or TH2?

A

TH2

(Slide 9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is TH2 asthma?

A

A TH2 condition; TH2 cells respond to an allergen by causing B-cell production of IgE and binding of IgE to mast cell IgE receptors.

Re-exposure to the allergen (such as pollen) then cross links receptors and cause mast cell degranulation

Eosinophil migration and activation also occurs, triggering long term damage

(Slide 9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is TH1 asthma?

A

TH1 cells produce IFN-γ and TNFα

TNFα then activates neutrophils which results in the long term damage

(Slide 9)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are 3 examples of structural changes / remodelling induced inflammation?

A

Epithelial damage

Goblet cell hyperplasia

Increased intraluminal secretions

Basements membrane thickening

Smooth muscle hypertrophy and hyperplasia

(Slide 10)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are 3 things airway smooth muscle do in patients with asthma when compared to healthy individuals?

A

Contracts more - due to an increased number of cytokines

Contracts more in response to methacholine - hyperresponsive

More stiffness - lack of breathing induced muscle softening

Increased muscle mass, leading to an increased force of contraction

In both normal as and asthmatic patients, the airway smooth muscle can release cytokines, but this can worsen symptoms for people with asthma

(Slide 12)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are 3 possible reasons why M3 induced contraction is more frequent / worse in patients with asthma when compared to healthy individuals?

A

Higher amounts of Rho kinase (due to cytokine mediated gene induction), which results in more sustained contraction

Higher levels of M3 receptors

Higher levels of signalling components, such as PLC or Gq

(Slide 15)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are hyperplasia and hypertrophy (2 things involved in smooth muscle proliferation) stimulated by?

A

Multiple growth factors and mediators which cause proliferation

(Slide 16)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can the airway smooth muscle releasing cytokines worsen symptoms in patients with asthma?

A

It can result in an autocrine loop, which can amplify inflammation and contribute to airway restructuring.

These mediators can also effect other cells

(Slide 16)

17
Q

Does airway muscle proliferate faster or slower in patients with asthma - how do we know this?

A

It proliferates faster, which we know as bronchial biopsies from patients proliferate more

(Slide 16)

18
Q

How does the MAPK pathway contribute in asthma? State the steps of the MAPK pathway

A
  1. In asthma, airway smooth muscle cells are exposed to a range of inflammatory mediators,
  2. These activate receptor tyrosine kinases (RTKs) or G-protein coupled receptors (GPCRs) on the surface of airway smooth muscle cells
  3. When receptors are activated, adaptor protein grb2 (growth factor receptor-bound protein 2) is recruited to the receptor complex where it binds to Son of Sevenless (SOS)
  4. SOS acts as a guanine nucleotide exchange factor for Ras, and activates Ras by facilitating the exchange of GDP for GTP
  5. Ras then interacts with Raf1, a serine threonine kinase, activating it.
  6. Raf1 then phosphorylates MEK (map kinase kinase)
  7. MEK phosphorylates ERK (MAP kinase), a protein kinase which translocates to the nucleus.
  8. ERK then regulates the activity of transcription factors (such as NF-κB), promoting genes that control cell proliferation, survival, inflammation and other important processes, which can contribute to asthma

Note: Bonus points for saying that binding to the RTK causes dimerization, and then RTKs undergo autophosphorylation via tyrosine residues and these phosphorylated RTKs then recruit Grb2

Above is stuff from last semester but it’ll count as extra reading for this class I think?

(Slide 17)

19
Q

How can increased parasympathetic activity occur and how can it contribute to asthma?

A

Increased activity can occur due to defects in cholinergic innervation.

This can result in:

Increased vagal tone (increased activity of the vagus nerve, the main parasympathetic nerve) - can lead to bronchoconstriction

Reflex bronchoconstriction

Increased acetylcholine release - which then binds to muscarinic receptors (specifically M3), causing bronchoconstriction

Increased post-synaptic muscarinic function - this means airway smooth muscle is more sensitive to acetylcholine, leading to stronger bronchoconstriction responses

(Slide 19)

20
Q

What are 2 examples of classes of mediators can increase acetylcholine release, which can help contribute to asthma?

A

Tachykinins and thromboxanes

(Slide 19)

21
Q

What are C-fibres?

A

Small, unmyelinated sensory nerve fibres that play a crucial role in detecting pain, temperature, and chemical irritants. They belong to the sensory nervous system (SNS).

(Slide 20)

22
Q

How do C-fibres contribute to asthma?

A
  1. Irritants stimulate C-fibres receptors. Inflammatory cells can also release mediators which sensitise C-fibres
  2. C-fibres send signals via the nodose ganglion to the CNS
  3. This activates the vagus nerve, which is the major parasympathetic nerve.
  4. The vagus nerve sends signals to a parasympathetic ganglion, releasing acetylcholine
  5. Acetylcholine stimulates muscarinic receptors on airway smooth muscle, leading to bronchoconstriction

(Slide 20)

23
Q

What is COPD?

A

It stands for Chronic Obstructive Pulmonary Disease (COPD) and is a chronic slowly progressive disorder characterised by airflow obstruction

(Slide 22)

24
Q

What does COPD reduce and what does ratio does this affect?

A

It reduces FEV1 (the maximum amount of air a person can forcefully exhale in one second) which reduces the FEV1/VC ratio.

VC stands for vital capacity and is the total amount of air a person can exhale after taking a full, deep breath

(Slide 22)

25
What are 3 features of the pathology of COPD?
Increased mucus gland thickness Airflow Limitation Circulatory Changes (only in advanced cases) (Slide 23)
26
What are 3 ways which the air flow limitation of COPD can be caused?
Via mechanical obstruction / inflammation Through loss of pulmonary elastic recoil Reduction of the alveolar attachment around the walls of the small airways (Slide 23)
27
What are 4 clinical symptoms of COPD?
Answers Include: Chronic Dyspnoea (shortness of breath or difficulty breathing) Wheezing (breathing with a whistling or rattling sound in the chest) Unintended Weight Loss Cough and Sputum (a mixture of saliva and mucus coughed up from the respiratory tract) Chest Tightness (Slide 24)
28
What are 4 risk factors for COPD?
Smoking or second-hand smoke Lung irritants (such as chemical fumes) Family History (AATD gene linked to COPD) History of respiratory infections as a child (Slide 25)
29
What are chronic bronchitis and emphysema?
Different forms of COPD which affect the lungs in different ways (Slide 26)
30
What causes chronic bronchitis and how does it affect the lungs? State 3 symptoms of this.
Chronic bronchitis is caused by chronic inflammation and narrowing of the airways, leading to increased mucus production and difficulty breathing. Symptoms include: A persistent cough, increased mucus production, shortness of breath and wheezing (Slide 26)
31
What causes emphysema and how does it affect the lungs? State 2 symptoms of this.
Emphysema is caused by destruction of the alveoli (air sacs) in the lungs, leading to a reduction in the surface area for gas exchange. Symptoms include: Shortness of breath, wheezing, and a feeling of not getting enough air (dyspnoea) (Slide 26)
32
What are the cellular mechanisms which lead to both chronic bronchitis and emphysema?
1. Irritants (such as cigarette smoke) activate epithelial cells lining the airways and alveolar macrophages 2. Both of these can activate neutrophils by releasing a variety of signalling molecules, such as pro-inflammatory cytokines or chemotactic factors 3. Macrophages and neutrophils can release proteases, and neutrophils can also release other mediators such as reactive oxygen species (ROS) 4a. Proteases released breakdown elastin, a key component of the extracellular matrix in the alveolar walls, leading to the destruction of the alveolar walls, resulting in the loss of lung elasticity and alveolar collapse, leading to a decreased surface area for gas exchange (emphysema) 4b. Proteases released degrade structural proteins in the bronchial walls, such as collagen or elastin , which weakens the airways and contributes to inflammation and airway remodelling. These processes lead to thickening of the bronchial walls, narrowing of the airways, and increased mucus production (chronic bronchitis) (Slides 27 and 28)
33
Why is the alpha 1 anti-trypsin gene important in COPD?
It encodes for alpha 1 anti-trypsin, which inhibits trypsin like proteases ("Pro elastin" in a way as it inhibits proteases which can break down elastin). It is responsible for balancing the activity of elastin and other destructive enzyme proteases produced during an infection / immune challenge Deletion of this gene results in a higher possibility of emphysema occurring (Slide 29)
34
What is the first line of the innate response to irritants?
The epithelial / mucosal barrier (Slide 30)
35
What are 3 immunological components which can be involved in COPD?
Answers Include: Epithelial / mucosal barrier being reduced over time Enhanced TH-1 and TH-17 signals CD8+ T cells doing direct damage through granzyme (a family of proteases) release Damaged cells / degraded proteins functioning as antigens. Their DAMPs stimulate the innate and adaptive immune systems M2 macrophages becoming dominant can lead to excessive healing, leading to excessive fibrosis and scar tissue forming (Slide 30)
36
What is bronchodilator reversibility?
The percentage increase in FEV1 after bronchodilation (Slide 31)
37
How is bronchodilator reversibility measured?
1. FEV1 is measured using spirometry 2. The patient is given a bronchodilator 3. After a few minutes (usually 15 - 30 mins), FEV 1 is measured again (Slide 31)
38
What is the criteria for bronchodilator reversibility to be considered significant?
An improvement in FEV1 of 12% or more after bronchodilator was administrated (Slide 31)